Robert Ainscow - ASP Isotopes Interim Officer
| ASPI Stock | USD 5.90 0.90 18.00% |
Insider
Robert Ainscow is Interim Officer of ASP Isotopes Common
| Age | 48 |
| Address | 1101 Pennsylvania Avenue NW, Washington, DC, United States, 20004 |
| Phone | 202 756 2245 |
| Web | https://aspisotopes.com |
Robert Ainscow Latest Insider Activity
Tracking and analyzing the buying and selling activities of Robert Ainscow against ASP Isotopes stock is an integral part of due diligence when investing in ASP Isotopes. Robert Ainscow insider activity provides valuable insight into whether ASP Isotopes is net buyers or sellers over its current business cycle. Note, ASP Isotopes insiders must abide by specific rules, including filing SEC forms every time they buy or sell ASP Isotopes'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Robert Ainscow over six months ago Acquisition by Robert Ainscow of 50000 shares of ASP Isotopes subject to Rule 16b-3 | ||
Robert Ainscow over a year ago Acquisition by Robert Ainscow of 50000 shares of ASP Isotopes subject to Rule 16b-3 |
ASP Isotopes Management Efficiency
The company has return on total asset (ROA) of (0.3933) % which means that it has lost $0.3933 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.9774) %, meaning that it created substantial loss on money invested by shareholders. ASP Isotopes' management efficiency ratios could be used to measure how well ASP Isotopes manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.64. The current Return On Capital Employed is estimated to decrease to -0.69. The ASP Isotopes' current Debt To Assets is estimated to increase to 0.02, while Total Assets are projected to decrease to under 18.3 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Martin Gagne | NanoXplore | N/A | |
| Laser Nedvidek | NanoXplore | 65 | |
| Gena Lovett | AdvanSix | 58 | |
| Futoshi Hamamoto | Asahi Kaisei Corp | N/A | |
| Yukihito Adachi | Shin Etsu Chemical Co | N/A | |
| Kelly Slieter | AdvanSix | 49 | |
| Mba LlB | NanoXplore | 58 | |
| Adam Kressel | AdvanSix | N/A | |
| Achilles Kintiroglou | AdvanSix | 45 | |
| Ichiro MD | Asahi Kaisei Corp | N/A | |
| Hiroki Ideguchi | Asahi Kaisei Corp | N/A | |
| Toshiyasu Horie | Asahi Kaisei Corp | 61 | |
| Yasuhiko Saitoh | Shin Etsu Chemical Co | 68 | |
| MBA BESc | NanoXplore | N/A | |
| Patrick Williams | AdvanSix | 55 | |
| Pedro Azevedo | NanoXplore | N/A | |
| Farha Aslam | AdvanSix | 52 | |
Management Performance
| Return On Equity | -1.98 | ||||
| Return On Asset | -0.39 |
ASP Isotopes Common Leadership Team
Elected by the shareholders, the ASP Isotopes' board of directors comprises two types of representatives: ASP Isotopes inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ASP. The board's role is to monitor ASP Isotopes' management team and ensure that shareholders' interests are well served. ASP Isotopes' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ASP Isotopes' outside directors are responsible for providing unbiased perspectives on the board's policies.
| M Sc, Chief Director | ||
| Paul CFA, CEO President | ||
| Xandra Heerden, Head Development | ||
| Robert Ainscow, Interim Officer | ||
| Hendrik Wyk, Head Engineering | ||
| Gerdus MD, Medical Labs | ||
| Paul Mann, CEO President | ||
| Heather Kiessling, Chief Officer |
ASP Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ASP Isotopes a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.98 | ||||
| Return On Asset | -0.39 | ||||
| Operating Margin | (7.29) % | ||||
| Current Valuation | 341.3 M | ||||
| Shares Outstanding | 71.16 M | ||||
| Shares Owned By Insiders | 34.34 % | ||||
| Shares Owned By Institutions | 16.53 % | ||||
| Number Of Shares Shorted | 6.45 M | ||||
| Price To Book | 9.22 X | ||||
| Price To Sales | 155.49 X |
Currently Active Assets on Macroaxis
When determining whether ASP Isotopes Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ASP Isotopes' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Asp Isotopes Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Asp Isotopes Common Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ASP Isotopes Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Diversified Metals & Mining space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ASP Isotopes. If investors know ASP will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ASP Isotopes listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.62) | Revenue Per Share 0.055 | Return On Assets (0.39) | Return On Equity (1.98) |
The market value of ASP Isotopes Common is measured differently than its book value, which is the value of ASP that is recorded on the company's balance sheet. Investors also form their own opinion of ASP Isotopes' value that differs from its market value or its book value, called intrinsic value, which is ASP Isotopes' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ASP Isotopes' market value can be influenced by many factors that don't directly affect ASP Isotopes' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ASP Isotopes' value and its price as these two are different measures arrived at by different means. Investors typically determine if ASP Isotopes is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ASP Isotopes' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.